drugset / Trial / NCT02535832

Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

NCT02535832

Phase 1 Completed 16 enrolled Ohio State University
RandomizedParallel-groupDouble-blindTreatment

Summary

Muscle strength helps determine a person's quality of life and functional independence. Patients with rheumatoid arthritis often suffer from muscle weakness and a pre-diabetic condition called insulin resistance. By doing this study, the investigators hope to learn why patients with rheumatoid arthritis (RA) suffer from muscle weakness.

Timeline

Start
2015-09
Primary completion
2022-10
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pioglitazone Small molecule 45 mg Oral

Indications